BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
- Friday, December 17, 2021, 7:01
- Finance
- Add a comment
FRANKLIN LAKES, N.J., Dec. 17, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has expanded the BD COR™ System to include a new MX instrument for high-throughput molecular testing for infectious diseases….
About the Author
adminasapcorp has written 42001 stories on this site.